IMPACT OF UPADACITINIB ON CARDIOVASCULAR EVENTS AND ON LIPID VALUES IN OLDER INFLAMMATORY BOWEL DISEASE PATIENTS WITH CARDIOVASCULAR RISK FACTORS

被引:0
|
作者
Choden, Tenzin
Goffinet, Aaron
Singh, Priyanka
Choi, David
Choi, Natalie K.
Cohen, Russell D.
Dalal, Sushila
Pekow, Joel
Cleveland, Noa Krugliak
Micic, Dejan
Rubin, David T.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1757
引用
收藏
页码:S509 / S509
页数:1
相关论文
共 50 条
  • [21] Inflammatory bowel disease Cardiovascular risk increased?
    Weiss, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (08): : 962 - 962
  • [22] Cardiovascular Risk in Individuals with Inflammatory Bowel Disease
    Biondi, Robertha Baccaro
    Salmazo, Pericles Sidnei
    Zanati Bazan, Silmeia Garcia
    Hueb, Joao Carlos
    Rupp de Paiva, Sergio Alberto
    Sassaki, Ligia Yukie
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 107 - 113
  • [23] The risk of cardiovascular complications in inflammatory bowel disease
    Czubkowski, Piotr
    Osiecki, Marcin
    Szymanska, Edyta
    Kierkus, Jaroslaw
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (04) : 481 - 491
  • [24] The risk of cardiovascular complications in inflammatory bowel disease
    Piotr Czubkowski
    Marcin Osiecki
    Edyta Szymańska
    Jarosław Kierkuś
    Clinical and Experimental Medicine, 2020, 20 : 481 - 491
  • [25] Inflammatory bowel disease and the risk of cardiovascular diseases
    Nunez, Paulina
    Garcia Mateo, Sandra
    Quera, Rodrigo
    Gomollon, Fernando
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (03): : 236 - 242
  • [26] Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid Clinic
    Schatz, Ulrike
    Fischer, Sabine
    Mueller, Gabriele
    Tselmin, Sergey
    Birkenfeld, Andreas L.
    Julius, Ulrich
    Maerz, Winfried
    Bornstein, Stefan R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 94 - 99
  • [27] Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease
    Hageman, Steven H. J.
    de Borst, Gert Jan
    Dorresteijn, Johannes A. N.
    Bots, Michiel L.
    Westerink, Jan
    Asselbergs, Folkert W.
    Visseren, Frank L. J.
    HEART, 2020, 106 (21) : 1686 - 1692
  • [28] Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox
    Zanoli, Luca
    Inserra, Gaetano
    Castellino, Pietro
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (08) : 705 - 706
  • [29] Conventional Risk Factors and Cardiovascular Outcomes of Patients with Inflammatory Bowel Disease with Confirmed Coronary Artery Disease
    Aggarwal, Ashish
    Atreja, Ashish
    Kapadia, Samir
    Lopez, Rocio
    Achkar, Jean-Paul
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (09) : 1593 - 1601
  • [30] Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs
    Olivera, Pablo A.
    Lasa, Juan S.
    Peretto, Giovanni
    Zuily, Stephane
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1231 - 1248